Encompass Health (MEX:EHC) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:EHC Encompass Health Corp MEX:EHC
76 GF Score
Price MXN2,068.00
GF Value MXN1,433.32
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Encompass Health Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Encompass Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was MXN1,108 Mil. Encompass Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was MXN48,558 Mil. Encompass Health's annualized EBITDA for the quarter that ended in Jun. 2026 was MXN26,775 Mil. Encompass Health's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 1.85.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Encompass Health's Debt-to-EBITDA or its related term are showing as below:

MEX:EHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.9   Med: 3.26   Max: 4.79
Current: 1.9

During the past 13 years, the highest Debt-to-EBITDA Ratio of Encompass Health was 4.79. The lowest was 1.90. And the median was 3.26.

MEX:EHC's Debt-to-EBITDA is ranked better than
55.6% of 482 companies
in the Healthcare Providers & Services industry
Industry Median: 2.2 vs MEX:EHC: 1.90

Encompass Health  (MEX:EHC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Encompass Health Debt-to-EBITDA Related Terms

Encompass Health Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Encompass Health's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encompass Health Debt-to-EBITDA Chart

Encompass Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Encompass Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

MEX:EHC vs DVA, UHS, ENSG: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, Encompass Health's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Encompass Health Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Encompass Health's Debt-to-EBITDA falls into.


MEX:EHC
76GF Score
Encompass Health Corp MEX:EHC
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Encompass Health Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Encompass Health's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1260.36295 + 47534.2021) / 26959.2465375
=1.81

Encompass Health's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1107.83575 + 48557.803875) / 26774.684843636
=1.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Encompass Health (MEX:EHC) Overvalued in 2026?

Based on GuruFocus' analysis, Encompass Health stock appears to be overvalued. The current stock price of MXN2,068.00 is trading 44.3% above its estimated GF Value™ of MXN1,433.32. GuruFocus considers Encompass Health to be Significantly Overvalued.

Key valuation signals for MEX:EHC:

  • Debt-to-EBITDA:
  • GF Value™: MXN1,433.32 vs. price of MXN2,068.00 (44.3% above fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Encompass Health Business Description

Other Exchanges EHC:USA
Address 9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
76GF Score

Get the complete analysis for MEX:EHC

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,068.00
Price
MXN1,433.32
GF Value